Targeting the PKN2-dependent survival of residual oncogene-driven lung tumors
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Department of Defense
Start Date
July 1, 2025
End Date
June 30, 2028
Administered By
Pharmacology & Cancer Biology
Awarded By
Department of Defense
Start Date
July 1, 2025
End Date
June 30, 2028